Most payer criteria require the PA request to document all of the following before approving HCPCS code J3111: A 77080 bone density scan confirms postmenopausal osteoporosis diagnosis with T-score at or below -2.5 (or -1.0 with fragility fracture history, depending on payer) High fracture risk determination by the prescribing physician Failure of or contraindication to prior bisphosphonate therapy, such as zoledronic acid (J3489), or another antiresorptive (payer-specific, but commonly required) Documentation that the patient has not already completed the 12-month maximum treatment duration for romosozumab Prescriber documentation that the patient meets cardiovascular risk thresholds per FDA labeling (romosozumab carries a cardiovascular risk boxed warning) T-score cutoffs and bisphosphonate failure requirements differ across payers
Every serving of Precision Engineered Performance Whey Protein delivers 25 grams of whey protein, providing high biological value protein muscle nourishment with naturally-occurring 5.5 grams of Branched Chain Amino Acids (BCAA), namely L-Leucine, L-Isoleucine and L-Valine
Yes, youll learn about BPC-157, its mechanisms, and its use cases
Explore the full peptide collection to find the research-grade compounds that support your work with the reliability labs depend on
[146] In 1955, Todd helped elucidate the structure of the vitamin
